JB Chemicals and Pharmaceuticals reports revenue growth of 10 per cent to Rs 601 crores in Q3 FY22
As per IQVIA, JB was the fastest-growing company among the top 30 companies for CY 2021
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
JB Chemicals and Pharmaceuticals
JB Chemicals and Pharmaceuticals to acquire brands from Sanzyme
The acquisition for approximately Rs 628 crores will mark the company's entry into the probiotics, therapeutic nutraceuticals and…
JB Chemicals closely watching for acquisition opportunities
Nikhil Chopra, CEO and Whole Time Director, JB Chemicals and Pharmaceuticals, tells Akanki Sharma about his focus on acquiring…
JB Chemicals and Pharmaceuticals records revenue growth of 34 per cent in Q2 FY22
Profit After Tax (PAT) was up by 32 per cent at Rs 98 crores in Q2 FY22
KKR to acquire controlling stake in JB Chemicals and Pharmaceuticals
KKR will make the investment through its subsidiaries, Tau Investments Holdings, Tau Holdco, and KKR Asia III Fund Investments
JB Chemicals Gujarat unit passes US FDA inspection with one observation
The observation does not impact continuity of the business and the company would continue its manufacturing activities in current…
JB Chemicals Gujarat unit passes US FDA inspection with one observation
The company proposes to address this observation in the next 15 days JB Chemicals and Pharmaceuticals said its Gujarat unit has…